Information

Dapagliflozin Propanediol is an SGLT2 inhibitor API used for the treatment of Type 2 Diabetes Mellitus. It works by reducing glucose reabsorption in the kidneys, promoting the excretion of excess glucose through urine and helping to improve glycemic control. It is widely used in oral antidiabetic formulations and is also associated with cardiovascular and renal health benefits.

Log in

See all the content and easy-to-use features by logging in or registering!